William Ackman’s Pershing Square Capital Management sold its stake in drugmaker Valeant Pharmaceuticals, whose stock plunged after questions were raised about its business and accounting practices.
from WSJ.com: US Business http://ift.tt/2n2sTPE
via IFTTT
No comments:
Post a Comment